ACADIAN ASSET MANAGEMENT LLC - VOYAGER THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of VOYAGER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,883
-40.7%
630,163
-12.4%
0.02%
-41.2%
Q2 2023$8,238
+44.0%
719,659
-3.1%
0.03%
+36.0%
Q1 2023$5,722
+40.3%
742,355
+11.0%
0.02%
+25.0%
Q4 2022$4,078
-99.9%
668,738
+19.5%
0.02%
+11.1%
Q3 2022$3,312,000
+47.7%
559,549
+47.5%
0.02%
+63.6%
Q2 2022$2,243,000
+18.8%
379,402
+53.0%
0.01%
+37.5%
Q1 2022$1,888,000
+27.2%
247,970
-54.8%
0.01%
+33.3%
Q4 2021$1,484,000
-26.9%
548,070
-29.0%
0.01%
-25.0%
Q3 2021$2,029,000
-26.3%
771,975
+15.8%
0.01%
-20.0%
Q2 2021$2,754,000
+18.6%
666,854
+35.2%
0.01%
+11.1%
Q1 2021$2,323,000
+213.5%
493,237
+375.2%
0.01%
+200.0%
Q4 2020$741,000
+211.3%
103,803
+365.9%
0.00%
+200.0%
Q3 2020$238,000
-89.4%
22,281
-87.5%
0.00%
-90.0%
Q2 2020$2,244,000
+6.4%
177,862
-22.9%
0.01%
-16.7%
Q1 2020$2,110,000
-19.8%
230,568
+22.2%
0.01%0.0%
Q4 2019$2,632,000
+203.6%
188,645
+274.5%
0.01%
+200.0%
Q3 2019$867,000
-54.9%
50,374
-28.7%
0.00%
-55.6%
Q2 2019$1,922,000
+116.0%
70,605
+51.8%
0.01%
+125.0%
Q1 2019$890,000
+105.5%
46,500
+1.0%
0.00%
+100.0%
Q4 2018$433,000
-32.3%
46,031
+40.6%
0.00%
-33.3%
Q2 2018$640,000
+966.7%
32,747
+919.8%
0.00%
Q1 2018$60,0003,211
+10603.3%
0.00%
Q3 2016$0
-100.0%
30
-98.3%
0.00%
Q2 2016$20,000
+81.8%
1,765
+46.0%
0.00%
Q1 2016$11,0001,2090.00%
Other shareholders
VOYAGER THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 6,391,176$60,077,00050.34%
ARMISTICE CAPITAL, LLC 2,836,000$26,658,0002.02%
Casdin Capital, LLC 1,128,075$10,604,0001.81%
BB BIOTECH AG 2,865,841$26,939,0000.86%
HIGHLINE CAPITAL MANAGEMENT, L.P. 1,284,697$12,076,0000.81%
Aevitas Wealth Management, Inc. 48,300$454,0000.46%
GREAT POINT PARTNERS LLC 365,132$3,432,0000.43%
Patriot Financial Group Insurance Agency, LLC 61,320$576,0000.38%
HARBOURVEST PARTNERS LLC 72,726$684,0000.32%
Birchview Capital, LP 33,000$310,0000.29%
View complete list of VOYAGER THERAPEUTICS INC shareholders